The Safety and Efficacy of AVI Stent for Treating Coronary Revascularization
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.
Also called NCT02117843
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,200 participants
- Sponsor
- Beijing AmsinoMed Medical Device Co., Ltd
- Registry
-
NCT02117843
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02117843. Allocation not applicable; no masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization
- Condition
- Ischemic Heart Disease
- Condition
- Myocardial Ischemia
- Condition
- Coronary Disease
- Condition
- Acute Coronary Syndrome
- Intervention (Device)
- AVI® Arsenic trioxide drug eluting stent
- Lead sponsor
- Beijing AmsinoMed Medical Device Co., Ltd
Record details
- Record id
cardio:ct-nct02117843- Content hash
885ab549eda114fea1d85337bb3d4cd564359b30829e2f799c77f99491e6a83f